202 related articles for article (PubMed ID: 36139375)
1. IgG
Couto N; Elzanowska J; Maia J; Batista S; Pereira CE; Beck HC; Carvalho AS; Strano Moraes MC; Carvalho C; Oliveira M; Matthiesen R; Costa-Silva B
Cells; 2022 Sep; 11(18):. PubMed ID: 36139375
[TBL] [Abstract][Full Text] [Related]
2. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
Han Y; Drobisch P; Krüger A; William D; Grützmann K; Böthig L; Polster H; Seifert L; Seifert AM; Distler M; Pecqueux M; Riediger C; Plodeck V; Nebelung H; Weber GF; Pilarsky C; Kahlert U; Hinz U; Roth S; Hackert T; Weitz J; Wong FC; Kahlert C
J Hematol Oncol; 2023 Feb; 16(1):7. PubMed ID: 36737824
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
[TBL] [Abstract][Full Text] [Related]
4. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
Xu X; Bhandari K; Xu C; Morris K; Ding WQ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108374
[TBL] [Abstract][Full Text] [Related]
5. CD63-positive extracellular vesicles are potential diagnostic biomarkers of pancreatic ductal adenocarcinoma.
Odaka H; Hiemori K; Shimoda A; Akiyoshi K; Tateno H
BMC Gastroenterol; 2022 Mar; 22(1):153. PubMed ID: 35350978
[TBL] [Abstract][Full Text] [Related]
6. Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals.
Roy JW; Wajnberg G; Ouellette A; Boucher JE; Lacroix J; Chacko S; Ghosh A; Ouellette RJ; Lewis SM
Sci Rep; 2023 Jun; 13(1):9251. PubMed ID: 37286718
[TBL] [Abstract][Full Text] [Related]
7. Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.
Yoshioka Y; Shimomura M; Saito K; Ishii H; Doki Y; Eguchi H; Nakatsura T; Itoi T; Kuroda M; Mori M; Ochiya T
Cancer Sci; 2022 Oct; 113(10):3498-3509. PubMed ID: 35848896
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
Takahashi K; Inuzuka T; Shimizu Y; Sawamoto K; Taniue K; Ono Y; Asai F; Koyama K; Sato H; Kawabata H; Iwamoto H; Yamakita K; Kitano Y; Teramoto T; Fujiya M; Fujii S; Mizukami Y; Okumura T
Pancreas; 2024 May; 53(5):e395-e404. PubMed ID: 38416857
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode.
Inoue H; Eguchi A; Kobayashi Y; Usugi E; Yamada R; Tsuboi J; Akuta T; Horiki N; Iwasa M; Takei Y
J Hepatobiliary Pancreat Sci; 2022 Mar; 29(3):394-403. PubMed ID: 34555251
[TBL] [Abstract][Full Text] [Related]
10. Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma.
Nesteruk K; Levink IJM; Dits NFJ; Cahen DL; Peppelenbosch MP; Bruno MJ; Fuhler GM
Clin Transl Gastroenterol; 2022 Feb; 13(3):e00465. PubMed ID: 35363220
[TBL] [Abstract][Full Text] [Related]
11. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.
Takahashi K; Ota Y; Kogure T; Suzuki Y; Iwamoto H; Yamakita K; Kitano Y; Fujii S; Haneda M; Patel T; Ota T
Cancer Sci; 2020 Jan; 111(1):98-111. PubMed ID: 31715081
[TBL] [Abstract][Full Text] [Related]
12. Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer.
Asada T; Nakahata S; Fauzi YR; Ichikawa T; Inoue K; Shibata N; Fujii Y; Imamura N; Hiyoshi M; Nanashima A; Morishita K
Anticancer Res; 2022 Apr; 42(4):1763-1775. PubMed ID: 35346995
[TBL] [Abstract][Full Text] [Related]
13. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
Zeöld A; Sándor GO; Kiss A; Soós AÁ; Tölgyes T; Bursics A; Szűcs Á; Harsányi L; Kittel Á; Gézsi A; Buzás EI; Wiener Z
Cell Mol Life Sci; 2021 Mar; 78(6):3005-3020. PubMed ID: 33237353
[TBL] [Abstract][Full Text] [Related]
14. Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
Guerreiro EM; Øvstebø R; Thiede B; Costea DE; Søland TM; Kanli Galtung H
PLoS One; 2020; 15(9):e0238591. PubMed ID: 32886718
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study.
Zhang W; Wang L; Li D; Campbell DH; Walsh BJ; Packer NH; Dong Q; Wang E; Wang Y
Anal Methods; 2022 Jun; 14(23):2255-2265. PubMed ID: 35612592
[TBL] [Abstract][Full Text] [Related]
16. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
17. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer.
Vahabi M; Comandatore A; Centra C; Blandino G; Morelli L; Giovannetti E
Semin Cancer Biol; 2023 Dec; 97():50-67. PubMed ID: 37956937
[TBL] [Abstract][Full Text] [Related]
18. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.
Yang KS; Im H; Hong S; Pergolini I; Del Castillo AF; Wang R; Clardy S; Huang CH; Pille C; Ferrone S; Yang R; Castro CM; Lee H; Del Castillo CF; Weissleder R
Sci Transl Med; 2017 May; 9(391):. PubMed ID: 28539469
[TBL] [Abstract][Full Text] [Related]
20. From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer.
Han S; Underwood P; Hughes SJ
Cytokine Growth Factor Rev; 2020 Feb; 51():61-68. PubMed ID: 32005635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
